Cloud Pharmaceuticals
Dr. Brennan is the founder, president, and former CEO of Gene Logic (NASDAQ: GLGC). His experience as a successful entrepreneur for a biotech company that uses information as a key part of its business model translates especially well to Cloud Pharmaceuticals. During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion. Dr. Brennan was previously a general partner at Oxford Bioscience Partners. He also served as vice president, business development for Boehringer Mannheim Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cloud Pharmaceuticals
Cloud Pharmaceuticals is changing the way drugs are discovered and developed. The worldwide pharmaceutical industry is in need of new drugs that target smaller market segments, are developed faster, and have novel IP, greater drug safety, efficacy, and affordability.